Literature DB >> 18571753

Nanotechnology and aptamers: applications in drug delivery.

Etgar Levy-Nissenbaum1, Aleksandar F Radovic-Moreno, Andrew Z Wang, Robert Langer, Omid C Farokhzad.   

Abstract

Nucleic acid ligands, also known as aptamers, are a class of macromolecules that are being used in several novel nanobiomedical applications. Aptamers are characterized by high affinity and specificity for their target, a versatile selection process, ease of chemical synthesis and a small physical size, which collectively make them attractive molecules for targeting diseases or as therapeutics. These properties will enable aptamers to facilitate innovative new nanotechnologies with applications in medicine. In this review, we will highlight recent developments in using aptamers in nanotechnology solutions for treating and diagnosing disease.

Mesh:

Substances:

Year:  2008        PMID: 18571753     DOI: 10.1016/j.tibtech.2008.04.006

Source DB:  PubMed          Journal:  Trends Biotechnol        ISSN: 0167-7799            Impact factor:   19.536


  65 in total

1.  In vivo PEG modification of vascular surfaces for targeted delivery.

Authors:  Timothy E Deglau; Timothy M Maul; Flordeliza S Villanueva; William R Wagner
Journal:  J Vasc Surg       Date:  2011-12-09       Impact factor: 4.268

2.  siRNA-aptamer chimeras on nanoparticles: preserving targeting functionality for effective gene silencing.

Authors:  Vaishali Bagalkot; Xiaohu Gao
Journal:  ACS Nano       Date:  2011-09-21       Impact factor: 15.881

Review 3.  Cell-specific aptamer-mediated targeted drug delivery.

Authors:  Jiehua Zhou; John J Rossi
Journal:  Oligonucleotides       Date:  2010-12-23

Review 4.  Tumor-targeted drug delivery with aptamers.

Authors:  Y Zhang; H Hong; W Cai
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

Review 5.  Recent advances in understanding oligonucleotide aptamers and their applications as therapeutic agents.

Authors:  Khaled S Allemailem; Ahmad Almatroudi; Mohammed A Alsahli; Ghaiyda Talal Basfar; Faris Alrumaihi; Arshad Husain Rahmani; Amjad Ali Khan
Journal:  3 Biotech       Date:  2020-11-24       Impact factor: 2.406

6.  An aptamer-functionalized chemomechanically modulated biomolecule catch-and-release system.

Authors:  Ankita Shastri; Lynn M McGregor; Ya Liu; Valerie Harris; Hanqing Nan; Maritza Mujica; Yolanda Vasquez; Amitabh Bhattacharya; Yongting Ma; Michael Aizenberg; Olga Kuksenok; Anna C Balazs; Joanna Aizenberg; Ximin He
Journal:  Nat Chem       Date:  2015-03-23       Impact factor: 24.427

7.  Aptamer-conjugated polymeric nanoparticles for targeted cancer therapy.

Authors:  Athulya Aravind; Yasuhiko Yoshida; Toru Maekawa; D Sakthi Kumar
Journal:  Drug Deliv Transl Res       Date:  2012-12       Impact factor: 4.617

8.  Aptamer-mediated delivery of chemotherapy to pancreatic cancer cells.

Authors:  Partha Ray; Marcus A Cheek; Mariam L Sharaf; Na Li; Andrew D Ellington; Bruce A Sullenger; Barbara Ramsay Shaw; Rebekah R White
Journal:  Nucleic Acid Ther       Date:  2012-10       Impact factor: 5.486

9.  Aptamer-targeted cell-specific RNA interference.

Authors:  Jiehua Zhou; John J Rossi
Journal:  Silence       Date:  2010-02-01

10.  Increased heating efficiency and selective thermal ablation of malignant tissue with DNA-encased multiwalled carbon nanotubes.

Authors:  Supratim Ghosh; Samrat Dutta; Evan Gomes; David Carroll; Ralph D'Agostino; John Olson; Martin Guthold; William H Gmeiner
Journal:  ACS Nano       Date:  2009-09-22       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.